<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413732"><TermName>Telcyta</TermName><TermPronunciation>(tel-SY-tuh)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called glutathione analogs. Also called TLK286.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713066" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Telcyta&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713065" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Telcyta&quot;" language="es" id="_4"/><SpanishTermName>Telcyta</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de análogo del glutatión. También se llama TLK286.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-03-24</DateFirstPublished><DateLastModified>2005-02-25</DateLastModified></GlossaryTerm>
